Jazz Pharmaceuticals plc (J7Z) - Total Liabilities

Latest as of March 2026: €7.33 Billion EUR ≈ $8.57 Billion USD

Based on the latest financial reports, Jazz Pharmaceuticals plc (J7Z) has total liabilities worth €7.33 Billion EUR (≈ $8.57 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jazz Pharmaceuticals plc - Total Liabilities Trend (2013–2025)

This chart illustrates how Jazz Pharmaceuticals plc's total liabilities have evolved over time, based on quarterly financial data. See Jazz Pharmaceuticals plc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Jazz Pharmaceuticals plc Competitors by Total Liabilities

The table below lists competitors of Jazz Pharmaceuticals plc ranked by their total liabilities.

Company	Country	Total Liabilities
Ecopro BM. Co. Ltd KQ:247540	Korea	₩2.66 Trillion
Penske Automotive Group Inc NYSE:PAG	USA	$12.64 Billion
Nantong Jianghai Capacitor Co Ltd SHE:002484	China	CN¥2.57 Billion
Jefferies Financial Group Inc NYSE:JEF	USA	$63.72 Billion
Trimble Inc NASDAQ:TRMB	USA	$3.35 Billion
Dynatrace Holdings LLC NYSE:DT	USA	$1.80 Billion
AVIC Jonhon Optronic Technology Co Ltd SHE:002179	China	CN¥16.19 Billion
Industrivarden AB ser. A ST:INDU-A	Sweden	Skr7.93 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Jazz Pharmaceuticals plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jazz Pharmaceuticals plc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jazz Pharmaceuticals plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jazz Pharmaceuticals plc (2013–2025)

The table below shows the annual total liabilities of Jazz Pharmaceuticals plc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€7.34 Billion ≈ $8.58 Billion	-7.30%
2024-12-31	€7.92 Billion ≈ $9.26 Billion	+3.42%
2023-12-31	€7.66 Billion ≈ $8.95 Billion	-1.20%
2022-12-31	€7.75 Billion ≈ $9.06 Billion	-7.01%
2021-12-31	€8.33 Billion ≈ $9.74 Billion	+189.74%
2020-12-31	€2.88 Billion ≈ $3.36 Billion	+18.46%
2019-12-31	€2.43 Billion ≈ $2.84 Billion	-0.74%
2018-12-31	€2.45 Billion ≈ $2.86 Billion	+1.47%
2017-12-31	€2.41 Billion ≈ $2.82 Billion	-17.53%
2016-12-31	€2.92 Billion ≈ $3.42 Billion	+68.57%
2015-12-31	€1.73 Billion ≈ $2.03 Billion	-11.88%
2014-12-31	€1.97 Billion ≈ $2.30 Billion	+108.74%
2013-12-31	€942.69 Million ≈ $1.10 Billion	--

About Jazz Pharmaceuticals plc

F:J7Z Germany Biotechnology

Market Cap

$14.31 Billion

€12.24 Billion EUR

Market Cap Rank

#2005 Global

#413 in Germany

Share Price

€195.15

Change (1 day)

-1.54%

52-Week Range

€90.06 - €207.10

All Time High

€207.10